Gene expression, micro‐CT and histomorphometrical analysis of sinus floor augmentation with biphasic calcium phosphate and deproteinized bovine bone mineral: A randomized controlled clinical trial
Clinical Implant Dentistry and Related Research · 2024
DOI: 10.1111/cid.13303 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Clinical Implant Dentistry and Related Research, 2024. Verfasst von Sirida Arunjaroensuk und 6 weiteren Autor:innen. Beteiligte Einrichtung: Dental Biomaterials Science Program, Graduate School, Chulalongkorn University, Bangkok, Thailand. Hauptthemen laut MEDLINE: Sinus Floor Augmentation, Bone Substitutes, Hydroxyapatites. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 79 Literaturangaben. Gefördert von: the 90th Anniversary of Chulalongkorn University Fund, the Second Century Fund (C2F), Chulalongkorn University.
Abstract (Originalsprache)
Aims
The aim of this randomized controlled clinical trial was to compare the gene expression, micro‐CT, histomorphometrical analysis between biphasic calcium phosphate (BCP) of 70/30 ratio and deproteinized bovine bone mineral (DBBM) in sinus augmentation. Materials and Methods Twenty‐four patients in need for sinus floor augmentation through lateral approach were randomized into BCP 70/30 ratio or DBBM. After at least 6 months of healing, a total of 24 bone specimens were collected from the entire height of the augmented bone at the area of implant placement and underwent micro‐CT, histomorphometric and gene expression analysis. The 12 bone specimens of BCP 70/30 ratio were equally allocated to micro‐CT and histologic analysis (test group, n = 6) and gene expression analysis (test group, n = 6). Similarly, the 12 bone specimens of DBBM were also allocated to micro‐CT and histologic analysis (control group, n = 6) and gene expression analysis (control group, n = 6). The newly formed bone, remaining graft materials and relative change in gene expression of four target genes were assessed.
Results
The micro‐CT results showed no statistically significant difference in the ratio of bone volume to total volume (BV/TV ratio) for the two groups (BCP 41.51% vs. DBBM 40.97%) and the same was true for residual graft material to total volume (GV/TV ratio, BCP 9.97% vs. DBBM 14.41%). Similarly, no significant difference was shown in the histological analysis in terms of bone formation, (BCP 31.43% vs. DBBM was 30.09%) and residual graft area (DBBM 40.76% vs. BCP 45.06%). With regards to gene expression, the level of ALP was lower in both groups of bone grafted specimens compared with the native bone. On the contrary, the level of OSX, IL‐1B and TRAP was higher in augmented bone of both groups compared with the native bone. However, the relative difference in all gene expressions between BCP and DBBM group was not significant.
Conclusions
The BCP, HA/β‐TCP ratio of 70/30 presented similar histological and micro‐CT outcomes in terms of new bone formation and residual graft particles with DBBM. The gene expression analysis revealed different gene expression patterns between augmented and native bone, but showed no significant difference between the two biomaterials.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Dental Biomaterials Science Program, Graduate School, Chulalongkorn University, Bangkok, Thailand.
- Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Chulalongkorn University, Bangkok, Thailand.
- Oral and Maxillofacial Surgery and Digital Implant Surgery Research Unit, Faculty of Dentistry, Chulalongkorn University, Bangkok, Thailand.
- Assistive Technology and Medical Devices Research Center (A-MED), National Science and Technology Development Agency (NSTDA), Pathum Thani, Thailand.
- Institute of Dentistry, Suranaree University of Technology, Nakhon Ratchasima, Thailand.
- Center of Excellence in Genomics and Precision Dentistry, Department of Physiology, Faculty of Dentistry, Chulalongkorn University, Bangkok, Thailand.
ORCID-Profile: Sirida Arunjaroensuk, Naruporn Monmaturapoj, Pasutha Thunyakitpisal, Thantrira Porntaveetus, Nikos Mattheos, Atiphan Pimkhaokham
Förderung
- the 90th Anniversary of Chulalongkorn University Fund
- the Second Century Fund (C2F), Chulalongkorn University
Zitieren
APA
Arunjaroensuk, S., Nampuksa, K., Monmaturapoj, N., Thunyakitpisal, P., Porntaveetus, T., Mattheos, N., & Pimkhaokham, A. (2024). Gene expression, micro‐CT and histomorphometrical analysis of sinus floor augmentation with biphasic calcium phosphate and deproteinized bovine bone mineral: A randomized controlled clinical trial. Clinical Implant Dentistry and Related Research. https://doi.org/10.1111/cid.13303
Vancouver
Arunjaroensuk S, Nampuksa K, Monmaturapoj N, Thunyakitpisal P, Porntaveetus T, Mattheos N, et al. Gene expression, micro‐CT and histomorphometrical analysis of sinus floor augmentation with biphasic calcium phosphate and deproteinized bovine bone mineral: A randomized controlled clinical trial. Clinical Implant Dentistry and Related Research. 2024. doi:10.1111/cid.13303
BibTeX
@article{Arunjaroensuk2024,
author = {Arunjaroensuk, Sirida and Nampuksa, Katanchalee and Monmaturapoj, Naruporn and Thunyakitpisal, Pasutha and Porntaveetus, Thantrira and Mattheos, Nikos and Pimkhaokham, Atiphan},
title = {Gene expression, micro‐CT and histomorphometrical analysis of sinus floor augmentation with biphasic calcium phosphate and deproteinized bovine bone mineral: A randomized controlled clinical trial},
journal = {Clinical Implant Dentistry and Related Research},
year = {2024},
doi = {10.1111/cid.13303}
}
EUVIMED